IRESSA in Combination With Cisplatin & Radiotherapy in Patients With Advanced Head & Neck Carcinoma

NCT00242749 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer of Head and Neck

Interventions

DRUG: Gefitinib, Cisplatin and Radiotherapy

Sponsor

AstraZeneca